Related references
Note: Only part of the references are listed.CB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodies
Hai-ying Zhang et al.
ACTA PHARMACOLOGICA SINICA (2019)
Integrated mRNA and miRNA profiling revealed deregulation of cellular stress response in bone marrow mesenchymal stem cells derived from patients with immune thrombocytopenia
Jia-Min Zhang et al.
FUNCTIONAL & INTEGRATIVE GENOMICS (2018)
Distinct alterations of CD68+ CD163+ M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment
Xia Shao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
The Levels of T Lymphocyte Subsets in Immune Thrombocytopenia Associated with Anti-GPIIb/IIIa- and/or Anti-GPIbα-Mediated Responses Are Differentially Sensitive to Dexamethasone
Yang Chen et al.
ACTA HAEMATOLOGICA (2018)
Glucocorticoid-induced osteoporosis: an update
Juliet Compston
ENDOCRINE (2018)
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency
Nadia Starc et al.
SCIENTIFIC REPORTS (2017)
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
Anne Zufferey et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Pathogenesis of immune thrombocytopenia
Sylvain Audia et al.
AUTOIMMUNITY REVIEWS (2017)
Pulsed high-dose dexamethasone modulates Th1-/Th2-chemokine imbalance in immune thrombocytopenia
Zongtang Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Imbalanced immune homeostasis in immune thrombocytopenia
Karina Yazdanbakhsh
SEMINARS IN HEMATOLOGY (2016)
Mesenchymal stem cells and immunomodulation: current status and future prospects
F. Gao et al.
CELL DEATH & DISEASE (2016)
Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression
Jia-min Zhang et al.
STEM CELLS TRANSLATIONAL MEDICINE (2016)
High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis
Siraj Mithoowani et al.
LANCET HAEMATOLOGY (2016)
Current Management of Primary Immune Thrombocytopenia
Drew Provan et al.
ADVANCES IN THERAPY (2015)
The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update
Waseem Ahmad Siddiqui et al.
ARCHIVES OF TOXICOLOGY (2015)
One Hormone, Two Actions: Anti- and Pro-Inflammatory Effects of Glucocorticoids
Diana Cruz-Topete et al.
NEUROIMMUNOMODULATION (2015)
Inhibition of B-Cell Proliferation and Antibody Production by Mesenchymal Stromal Cells Is Mediated by T Cells
Maria Manuela Rosado et al.
STEM CELLS AND DEVELOPMENT (2015)
T cells and their cytokines in persistent stimulation of the immune system
Hassen Kared et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
High-dose dexamethasone modulates serum cytokine profile in patients with primary immune thrombocytopenia
Yanxia Zhan et al.
IMMUNOLOGY LETTERS (2014)
The interaction between mesenchymal stem cells and steroids during inflammation
X. Chen et al.
CELL DEATH & DISEASE (2014)
Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids
Maria Grazia Petrillo et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
The Cannabinoid Receptor Type 2 as Mediator of Mesenchymal Stromal Cell Immunosuppressive Properties
Francesca Rossi et al.
PLOS ONE (2013)
Immune thrombocytopenia: serum cytokine levels in children and adults
Jasminka Pavelić
MEDICAL SCIENCE MONITOR (2013)
Dexamethasone has variable effects on mesenchymal stromal cells
Hanyu Wang et al.
CYTOTHERAPY (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity
Xin Chen et al.
FEBS LETTERS (2011)
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
Francesca Rossi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura
Jose Antonio Perez-Simon et al.
CYTOTHERAPY (2009)
Human Mesenchymal Stem Cells and Immunosuppressive Drug Interactions in Allogeneic Responses: An In Vitro Study Using Human Cells
F. Buron et al.
TRANSPLANTATION PROCEEDINGS (2009)
Abnormality of CD4+CD25+ regulatory T cells in idiopathic thrombocytopenic purpura
Bin Liu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
How corticosteroids control inflammation: Quintiles prize lecture 2005
Peter J. Barnes
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-κB-dependent apoptosis:: Novel role for endogenous and exogenous cannabinoids in immunoregulation
Y Do et al.
JOURNAL OF IMMUNOLOGY (2004)
Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells
M Yuan et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
M Di Nicola et al.
BLOOD (2002)
The cannabinoid system and cytokine network
TW Klein et al.
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (2000)
Share Paper
